Fast Market Research

New Market Report Now Available: Biotica Technology Ltd - Product Pipeline Review - 2013

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 07/24/2013 -- Global Market Direct's pharmaceuticals report, "Biotica Technology Ltd - Product Pipeline Review - 2013" provides data on the Biotica Technology Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Biotica Technology Ltd's corporate website, SEC filings, investor presentations and featured press releases, both from Biotica Technology Ltd and industry-specific third party sources, put together by Global Markets Direct's team.


- Biotica Technology Ltd - Brief Biotica Technology Ltd overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Biotica Technology Ltd human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Biotica Technology Ltd with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Biotica Technology Ltd's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Biotica Technology Ltd's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Biotica Technology Ltd in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Biotica Technology Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Biotica Technology Ltd.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Biotica Technology Ltd and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Biotica Technology Ltd - Product Pipeline Review - 2012
- Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2013
- Johnson & Johnson - Product Pipeline Review - 2013
- AstraZeneca PLC - Product Pipeline Review - 2013
- Pfizer Inc. - Product Pipeline Review - 2013
- Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2013
- F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2013
- ImmunoGen, Inc. - Product Pipeline Review - 2013
- Bristol-Myers Squibb Company - Product Pipeline Review - 2013
- Generex Biotechnology Corporation - Product Pipeline Review - 2013